Agency Forms Undergoing Paperwork Reduction Act Review, 10489-10491 [2015-03985]
Download as PDF
<![CDATA[
10489
Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices
Background and Brief Description
The compilation of national vital
statistics dates back to the beginning of
the 20th century and has been
conducted since 1960 by the Division of
Vital Statistics of the National Center for
Health Statistics, CDC. The collection of
the data is authorized by 42 U.S.C. 242k.
This submission requests approval to
collect the monthly and annually
summary statistics for three years.
The Monthly Vital Statistics Report
forms provide counts of monthly
occurrences of births, deaths, infant
deaths, marriages, and divorces. Similar
data have been published since 1937
and are the sole source of these data at
the National level. The data are used by
the Department of Health and Human
Services and by other government,
academic, and private research and
commercial organizations in tracking
changes in trends of vital events.
Respondents for the Monthly Vital
Statistics Reports Form are registration
officials in each State and Territory, the
District of Columbia, and New York
City. In addition, local (county) officials
in New Mexico who record marriages
occurring and divorces and annulments
granted in each county of New Mexico
will use this form. This form is also
designed to collect counts of monthly
occurrences of births, deaths, infant
deaths, marriages, and divorces
immediately following the month of
occurrence.
The Annual Vital Statistics
Occurrence Report Form collects final
annual counts of marriages and divorces
by month for the United States and for
each State. The statistical counts
requested on this form differ from
provisional estimates obtained on the
Monthly Vital Statistics Report Form in
that they represent complete counts of
marriages, divorces, and annulments
occurring during the months of the prior
year. These final counts are usually
available from State or county officials
about eight months after the end of the
data year. The data are widely used by
government, academic, private research,
and commercial organizations in
tracking changes in trends of family
formation and dissolution. Respondents
for the Annual Vital Statistics
Occurrence Report Form are registration
officials in each State and Territory, the
District of Columbia, and New York
City.
There are no costs to respondents
other than their time. The total estimate
annualized burden hours are 211.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
Type of respondents
Form name
State, Territory, and New Mexico County Officials.
State, Territory, and other officials .................
Monthly Vital Statistics Report .......................
91
12
10/60
Annual Vital Statistics Occurrence Report .....
58
1
30/60
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–03989 Filed 2–25–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–15–15CK]
rmajette on DSK2VPTVN1PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
VerDate Sep<11>2014
15:27 Feb 25, 2015
Jkt 235001
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
comments should be received within 30
days of this notice.
Proposed Project
Improving the Impact of Laboratory
Practice Guidelines (LPGs): A New
Paradigm for Metrics- College of
American Pathologists—NEW—Center
for Surveillance, Epidemiology and
Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention is funding three 5-year
projects collectively entitled ‘‘Improving
the Impact of Laboratory Practice
Guidelines: A New Paradigm for
Metrics’’. An ‘‘LPG’’ is defined as
written recommendations for voluntary,
standardized approaches for medical
laboratory testing that takes into account
processes for test selection, sample
procurement and processing, analytical
methods, and results reporting for
effective diagnosis and management of
disease and health conditions. LPGs
may be disseminated to, and used by,
laboratorians and clinicians to assist
with test selection and test result
interpretation. The overall purpose of
these cooperative agreements is to
increase the effectiveness of LPGs by
defining measures and collecting
information to inform better LPG
E:\FR\FM\26FEN1.SGM
26FEN1
10490
Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices
creation, revision, dissemination,
promotion, uptake, and impact on
clinical testing and public health.
The project will explore how these
processes and their impediments and
facilitators differ among various
intended users of LPGs. Through this
demonstration project, CDC seeks to
understand how to customize LPG
creation and promotion to better serve
these intended users of LPGs. An
important goal is to help organizations
that sponsor the development of LPGs
create a sustainable approach for
continuous quality improvement to
evaluate and improve an LPG’s impact
through better collection of information.
The CDC selected three organizations
that currently create and disseminate
LPGs to support activities under a
cooperative agreement funding
mechanism to improve the impact of
their LPGs. The American Society for
Microbiology (ASM), the Clinical and
Laboratory Standards Institute (CLSI),
and the College of American
Pathologists (CAP), will each use their
LPGs as models to better understand
how to improve uptake and impact of
these and future LPGs. Only the CAP
submission will be described in this
notice.
The CAP project will address two
LPGs that are important to clinical
testing: immunohistochemistry test
validation (IHC) and an algorithm for
diagnosing acute leukemia (ALA). The
ALA LPG is being co-developed with
the American Society of Hematology
(ASH). The intended users of the CAP’s
IHC LPGs will include pathologists,
clinical laboratory directors, and
laboratory managers overseeing the IHC
staining department. For the CAP’s ALA
LPG the intended users are pathologists
and hematologists overseeing testing for
acute leukemia. Thus, all these
professionals will be surveyed by CAP.
Prior to entering into this cooperative
agreement project with the CDC, the
CAP had already completed a baseline
IHC LPG information collection from
laboratories that used IHC testing.
Subsequent to this information
collection, the CAP created and
disseminated an IHC LPG in a peer
reviewed journal. Because of this prior
baseline assessment, the CAP will only
need to collect post-dissemination data.
For their ALA LPG CAP/ASH Algorithm
for Initial Work-Up of Acute Leukemia,
the CAP will conduct both a baseline
and a post-dissemination evaluation
using a survey and/or focus group.
Because there are uncertainties
concerning the specific focus group
probes for the IHC LPG and the ALA
LPG, this notice only provides a
description of our collection of postdissemination information for the IHC
LPG and the baseline ALA LPG.
The CAP hopes to achieve an 80%
response rate, or 2668 out of 3335
potential respondents for the IHC LPG.
This represents laboratories known to be
currently performing IHC testing based
upon their participation in CAP’s IHC
proficiency testing (PT) program and
450 additional laboratories identified by
CDC using previous Centers for
Medicare and Medicaid Services Part B
reimbursement claims for IHC testing.
The response rate for the baseline IHC
survey was approximately 70% and
more focused promotion is planned. We
have identified a total of 3335 (2885
CAP–PT customers + 450 non-CAP–PT
customers) laboratories that will be
targeted by the IHC post-dissemination
survey. Both populations represent
laboratories that are CAP-accredited and
non-CAP-accredited.
Laboratories that are enrolled in CAP
IHC PT programs will receive surveys
with their PT mailings. Non-CAP–PTcustomer laboratories will be surveyed
via the US postal system, with a faxback mechanism. Only one response per
laboratory will be accepted.
The CAP will need to collect both
baseline and post-guideline
dissemination information for the ALA
LPG. CAP will allow only one response
per computer internet protocol address.
The CAP has a database of pathologists
who have indicated specialization in
hematopathology; these
hematopathologists will be invited to
participate. The CAP hopes to achieve
an 80% response rate with their
individual information collections, or
880 (80% x 1100 pathologists listed in
the CAP database).
The baseline survey for the ALA
guideline includes questions about
individual practices for diagnosing
various types of acute leukemia and
individual and laboratory reporting
practices. The link to the baseline
survey for the ALA guideline will be
disseminated via email to
hematopathologists in CAP’s database.
The online survey will be hosted by
Survey Monkey.
The CAP and CDC will strive to
ensure a high response rate for their IHC
and ALA surveys. CAP plans to
advertise both surveys. Similarly, the
CAP plans to maximize response rates
for CAP–PT customer laboratories by
sending reminders through the PT
program. The CAP will also try to
maximize response rates for the ALA
survey by advertising it through various
channels and sending an email
reminder.
For burden calculation, we assume
one response per laboratory for the IHC
survey to include (1) pathologists, (2)
laboratory directors, and (3) other
laboratory managers of IHC laboratories,
which may consist of graduate level
scientists (Ph.D.s and Masters level),
approximately in a 25%:25%:50%
distribution, respectively. We assume
respondents for the ALA surveys may
include multiple responses within a
laboratory of pathologists and
hematologists that sign out cases,
approximately in a 95%:5%
distribution, respectively.
The IHC baseline survey, which was
conducted prior to this CAP–CDC
cooperative agreement, took 15 minutes
to complete. The IHC postdissemination survey is expected to take
20 minutes to complete. The ALA
baseline survey is expected to take an
average of 25 minutes to complete. The
maximum times observed during pilot
testing were 30 and 45 minutes,
respectively. Results from the pilot tests
were used to revise both surveys.
The total Estimated Annualized
Burden Hours for this ICR is 1,570.
There are no costs to respondents other
than their time.
rmajette on DSK2VPTVN1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Pathologists ....................................................
Laboratory Directors .......................................
Laboratory Managers ......................................
Hematologists .................................................
VerDate Sep<11>2014
15:27 Feb 25, 2015
Jkt 235001
Number of
respondents
Form name
IHC
ALA
IHC
IHC
ALA
PO 00000
.................................................................
.................................................................
.................................................................
.................................................................
.................................................................
Frm 00036
Fmt 4703
Sfmt 4703
E:\FR\FM\26FEN1.SGM
834
1,045
834
1,667
55
26FEN1
Number of
responses per
respondent
1
1
1
1
1
Avgerage
burden per
response
(in hrs.)
20/60
25/60
20/60
20/60
25/60
Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–03985 Filed 2–25–15; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[CDC–2015–0005, Docket Number NIOSH–
281]
BILLING CODE 4163–18–P
Future Directions for the Surveillance
of Agricultural Injuries; Public Meeting;
Request for Comments
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of public meeting and
request for comment.
AGENCY:
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Comprehensive High-Impact
HIV Prevention Projects for CommunityBased Organizations, Funding
Opportunity Announcement (FOA)
PS15–1502, Initial Review.
This document corrects a
notice that was published in the Federal
Register on February 9, 2015, Volume
80, Number 26, pages 6971 and 6972.
The times and dates should read as
follows:
SUMMARY:
Times and Dates:
9 a.m.–4 p.m., Panels 1–5; March 3,
2015 (Closed).
9 a.m.–4 p.m., Panels 6–12; March 6,
2015 (Closed).
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
DATES:
rmajette on DSK2VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Elizabeth Wolfe, Public Health Advisor,
CDC, 1600 Clifton Road NE., Mailstop
E07, Atlanta, Georgia 30333, Telephone:
(404) 639–8135.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–03952 Filed 2–25–15; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
15:27 Feb 25, 2015
Jkt 235001
The National Institute for
Occupational Safety and Health of the
Centers for Disease Control and
Prevention announces a public meeting
and an opportunity to comment on
future directions for the surveillance of
injuries within the agricultural
production industry. To view the notice
and related materials visit https://
www.regulations.gov and enter CDC–
2015–0005 in the search field and click
‘‘Search.’’
Public comment period: Comments
must be received May 27, 2015.
SUMMARY:
Table of Contents
• DATE
• FOR FURTHER INFORMATION
CONTACT
• SUPPLEMENTARY INFORMATION
I. Background
II. Public Meeting
III. Written Comments
A public meeting will be held on
March 30, 2015, 1:00 p.m.–5:00 p.m.
Eastern Time, or after the last public
commenter has spoken, whichever
occurs first. The public meeting will be
held as a web-based conference only
available by remote access.
FOR FURTHER INFORMATION CONTACT:
Kitty Hendricks, Division of Safety
Research, 1095 Willowdale Road, MS
1808, Morgantown, West Virginia
26505–2888, (304) 285–5916 (not a toll
free number) or khendricks@cdc.gov.
SUPPLEMENTARY INFORMATION:
I. Background: NIOSH began a
coordinated program in 1990 to address
safety and health issues for workers and
families in the US agricultural
production industry. In support of this
program, NIOSH established an
ongoing, national-level surveillance
system to monitor injuries to hired farm
workers, farmers, and farm family
members. Data for the injury
surveillance system are primarily
DATES:
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
10491
collected through surveys funded by
NIOSH and conducted by the US
Department of Agriculture’s National
Agricultural Statistics Service (USDA–
NASS) and the US Department of Labor
(DOL). These surveillance data are used
by NIOSH and others to estimate
injuries and injury rates and identify
safety hazards that increase injury risk.
Surveillance data have also been used
to show that the US agricultural
production industry has changed. Over
the past quarter century, both the size of
the workforce and the number of
injuries have declined. To maintain
statistically stable injury estimates with
the current approach of national-level
surveys, sample sizes would need to be
increased. As a result, this approach has
become more resource-intensive and is
no longer tenable for NIOSH.
Beginning in 2015, NIOSH will not
reestablish interagency agreements with
USDA–NASS and DOL to collect survey
data for the agricultural injury
surveillance system. This change in
surveillance approach presents an
opportunity for NIOSH to receive
stakeholder input and rigorously
examine future options for agricultural
injury surveillance.
To identify and assess different
options, NIOSH plans the following
activities: Hold the public meeting
announced in this notice to initiate a
national conversation regarding future
agricultural injury surveillance; seek
additional public comments through
this docket on the most urgent priorities
for injury surveillance in production
agriculture; examine what NIOSH and
agricultural injury stakeholders can do
to meet the overall need for agricultural
injury surveillance; support a
comprehensive, independent
assessment of recommendations
resulting from a 2007 National Academy
of Sciences (NAS) review and a 2012
follow-up independent panel review;
continue to engage with interested
parties as NIOSH plans its own future
directions for agricultural injury
surveillance; and seek input on the need
for a follow-up public meeting in Fall
2015 to discuss NIOSH’s future plans
after having considered input received
through the public meeting and public
comment period.
NIOSH is especially interested in
comments related to finding new ways
of doing surveillance using smarter,
more cost-effective approaches; shifting
surveillance from national to regional or
local approaches, in recognition of the
diversity of agricultural types in
different parts of the country; and
examining roles that partners can take to
address the need for smarter agricultural
injury surveillance.
E:\FR\FM\26FEN1.SGM
26FEN1
]]>Agencies
[Federal Register Volume 80, Number 38 (Thursday, February 26, 2015)]
[Notices]
[Pages 10489-10491]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-03985]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-15-15CK]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Improving the Impact of Laboratory Practice Guidelines (LPGs): A
New Paradigm for Metrics- College of American Pathologists--NEW--Center
for Surveillance, Epidemiology and Laboratory Services (CSELS), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention is funding three 5-
year projects collectively entitled ``Improving the Impact of
Laboratory Practice Guidelines: A New Paradigm for Metrics''. An
``LPG'' is defined as written recommendations for voluntary,
standardized approaches for medical laboratory testing that takes into
account processes for test selection, sample procurement and
processing, analytical methods, and results reporting for effective
diagnosis and management of disease and health conditions. LPGs may be
disseminated to, and used by, laboratorians and clinicians to assist
with test selection and test result interpretation. The overall purpose
of these cooperative agreements is to increase the effectiveness of
LPGs by defining measures and collecting information to inform better
LPG
[[Page 10490]]
creation, revision, dissemination, promotion, uptake, and impact on
clinical testing and public health.
The project will explore how these processes and their impediments
and facilitators differ among various intended users of LPGs. Through
this demonstration project, CDC seeks to understand how to customize
LPG creation and promotion to better serve these intended users of
LPGs. An important goal is to help organizations that sponsor the
development of LPGs create a sustainable approach for continuous
quality improvement to evaluate and improve an LPG's impact through
better collection of information.
The CDC selected three organizations that currently create and
disseminate LPGs to support activities under a cooperative agreement
funding mechanism to improve the impact of their LPGs. The American
Society for Microbiology (ASM), the Clinical and Laboratory Standards
Institute (CLSI), and the College of American Pathologists (CAP), will
each use their LPGs as models to better understand how to improve
uptake and impact of these and future LPGs. Only the CAP submission
will be described in this notice.
The CAP project will address two LPGs that are important to
clinical testing: immunohistochemistry test validation (IHC) and an
algorithm for diagnosing acute leukemia (ALA). The ALA LPG is being co-
developed with the American Society of Hematology (ASH). The intended
users of the CAP's IHC LPGs will include pathologists, clinical
laboratory directors, and laboratory managers overseeing the IHC
staining department. For the CAP's ALA LPG the intended users are
pathologists and hematologists overseeing testing for acute leukemia.
Thus, all these professionals will be surveyed by CAP.
Prior to entering into this cooperative agreement project with the
CDC, the CAP had already completed a baseline IHC LPG information
collection from laboratories that used IHC testing. Subsequent to this
information collection, the CAP created and disseminated an IHC LPG in
a peer reviewed journal. Because of this prior baseline assessment, the
CAP will only need to collect post-dissemination data. For their ALA
LPG CAP/ASH Algorithm for Initial Work-Up of Acute Leukemia, the CAP
will conduct both a baseline and a post-dissemination evaluation using
a survey and/or focus group. Because there are uncertainties concerning
the specific focus group probes for the IHC LPG and the ALA LPG, this
notice only provides a description of our collection of post-
dissemination information for the IHC LPG and the baseline ALA LPG.
The CAP hopes to achieve an 80% response rate, or 2668 out of 3335
potential respondents for the IHC LPG. This represents laboratories
known to be currently performing IHC testing based upon their
participation in CAP's IHC proficiency testing (PT) program and 450
additional laboratories identified by CDC using previous Centers for
Medicare and Medicaid Services Part B reimbursement claims for IHC
testing. The response rate for the baseline IHC survey was
approximately 70% and more focused promotion is planned. We have
identified a total of 3335 (2885 CAP-PT customers + 450 non-CAP-PT
customers) laboratories that will be targeted by the IHC post-
dissemination survey. Both populations represent laboratories that are
CAP-accredited and non-CAP-accredited.
Laboratories that are enrolled in CAP IHC PT programs will receive
surveys with their PT mailings. Non-CAP-PT-customer laboratories will
be surveyed via the US postal system, with a fax-back mechanism. Only
one response per laboratory will be accepted.
The CAP will need to collect both baseline and post-guideline
dissemination information for the ALA LPG. CAP will allow only one
response per computer internet protocol address. The CAP has a database
of pathologists who have indicated specialization in hematopathology;
these hematopathologists will be invited to participate. The CAP hopes
to achieve an 80% response rate with their individual information
collections, or 880 (80% x 1100 pathologists listed in the CAP
database).
The baseline survey for the ALA guideline includes questions about
individual practices for diagnosing various types of acute leukemia and
individual and laboratory reporting practices. The link to the baseline
survey for the ALA guideline will be disseminated via email to
hematopathologists in CAP's database. The online survey will be hosted
by Survey Monkey.
The CAP and CDC will strive to ensure a high response rate for
their IHC and ALA surveys. CAP plans to advertise both surveys.
Similarly, the CAP plans to maximize response rates for CAP-PT customer
laboratories by sending reminders through the PT program. The CAP will
also try to maximize response rates for the ALA survey by advertising
it through various channels and sending an email reminder.
For burden calculation, we assume one response per laboratory for
the IHC survey to include (1) pathologists, (2) laboratory directors,
and (3) other laboratory managers of IHC laboratories, which may
consist of graduate level scientists (Ph.D.s and Masters level),
approximately in a 25%:25%:50% distribution, respectively. We assume
respondents for the ALA surveys may include multiple responses within a
laboratory of pathologists and hematologists that sign out cases,
approximately in a 95%:5% distribution, respectively.
The IHC baseline survey, which was conducted prior to this CAP-CDC
cooperative agreement, took 15 minutes to complete. The IHC post-
dissemination survey is expected to take 20 minutes to complete. The
ALA baseline survey is expected to take an average of 25 minutes to
complete. The maximum times observed during pilot testing were 30 and
45 minutes, respectively. Results from the pilot tests were used to
revise both surveys.
The total Estimated Annualized Burden Hours for this ICR is 1,570.
There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Avgerage
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Pathologists.......................... IHC..................... 834 1 20/60
ALA..................... 1,045 1 25/60
Laboratory Directors.................. IHC..................... 834 1 20/60
Laboratory Managers................... IHC..................... 1,667 1 20/60
Hematologists......................... ALA..................... 55 1 25/60
----------------------------------------------------------------------------------------------------------------
[[Page 10491]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-03985 Filed 2-25-15; 8:45 am]
BILLING CODE 4163-18-P
